Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection. - Zeuli JD; Rivera CG; Smith BL; Otto A; Temesgen Z (Drugs of today (Barcelona, Spain : 1998), 2022)